| Genome-Wide Profiles of Extra-Cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways | HMC000099 | cancer, pediatric, childhood, SMARB1, WGS, WGBS, RNA-seq, miRNA-seq, ChIP-seq, epigenetic, neural crest cells | 67 | cancer, rhabdoid cancer, kidney rhabdoid cancer | Human Embryonic Stem (hES) cell lines (3): H7, H9 and H14, MRT cell lines (3): G401, KP-MRT-RY and KP-MRT-NS, Matched Normal (16 adjacent kidney + 24 peripheral blood), Primary Extra-cranial MRT from liver (2), Primary Extra-cranial MRT from soft tissues (7), Primary Extra-cranial MRT from kidneys (58) | Extra-cranial Malignant Rhabdoid Tumors, Kidney, MRT cell lines, Peripheral Blood, hESC cell lines | Epigenomics, Genomics, Transcriptomics | ChIP-seq for H3K27ac (histone modification), ChIP-seq for H3K27me3 (histone modification), DNA Methylation: WGBS (Whole Genome Bisulfite Sequencing), MicroRNA-seq, RNA-seq, Whole Genome Sequencing (WGS) | Genome British Columbia, Canada Foundation for Innovation, Canadian Institutes of Health Research (CIHR) |